eleven patients with advanced multiple myeloma refractory to standard doses of alkylating agents and salvage therapy with vincristine , adriamycin and dexamethasone ( vad ) were treated with high dose cyclophosphamide , bcnu and vp-16 ( cbv ) with autologous blood stem cell support .
C0026764
multiple myeloma
C0007257
bcnu